Form 8-K - Current report:
SEC Accession No. 0001193125-25-035787
Filing Date
2025-02-26
Accepted
2025-02-26 07:05:22
Documents
15
Period of Report
2025-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d924231d8k.htm   iXBRL 8-K 26679
2 EX-99.1 d924231dex991.htm EX-99.1 79637
6 GRAPHIC g924231dsp5.jpg GRAPHIC 6116
  Complete submission text file 0001193125-25-035787.txt   254467

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20250226.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20250226_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20250226_pre.xml EX-101.PRE 11725
17 EXTRACTED XBRL INSTANCE DOCUMENT d924231d8k_htm.xml XML 3802
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 25666126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)